OPQ- Drug Sampling and Testing Program
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- Points of contact
-
- Christopher Scott christopher.scott@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration (FDA) is forecasting a Drug Sampling and Testing Program through the Office of Pharmaceutical Quality (OPQ), scheduled for solicitation release on June 1, 2026, with an estimated contract award date of August 1, 2026. The contract falls under NAICS code 424210 for Drugs and Druggists' Sundries Merchant Wholesalers, indicating a focus on pharmaceutical wholesale and testing services. This new requirement appears to involve comprehensive drug sampling and evaluation protocols for pharmaceutical quality assurance.
While specific budget details are not available, the contract will be managed through the FDA without any specific set-aside provisions. Potential vendors can contact Christopher Scott at christopher.scott@fda.hhs.gov for further information about the opportunity. The point of contact is affiliated with the Food and Drug Administration organization, suggesting that communication and potential clarifications will be channeled through this federal contact for interested businesses seeking to participate in the drug sampling and testing program.
Forecast text
OPQ- Drug Sampling and Testing Program
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast